|
⚲
|
| DOR Biopharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0000812796 |
| Sale | 2009-03-06 ($0.4 M Offered, $0.3 M Sold) |
| Fund | |
| Phone | 6095388200 |
| Address | 850 Bear Tavern Road Ewing, 08628 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Evan Myrainthopoulos | |
| Christopher Schaber | |
| Cyrille Buhrman | |
| Greg Lapointe | |
| James Clavijo | |
| Evan Myrianthopoulos | |
| Robert Brey | |
| James Kuo | |
| Brian Hamilton |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Brown Advisory Investors 2023 - CRC SoCo Co-Invest, LLLP
✚
|
0.0 | |
|
Brown Advisory Investors 2023 - Crockett Partners, LLLP
✚
|
0.0 | |
|
Brown Advisory Venture Capital Partners 4, LLLP
✚
|
0.0 | |
|
Incline Elevate Fund II LP
✚
|
0.0 | |
|
Incline Elevate Fund II-A LP
✚
|
0.0 | |
|
Inderkum David J
✚
|
0.0 | |
|
IND Fund I, a series of AX-RN-Funds, LP
✚
|
0.0 | |
|
BTR 2012 GST Trust for Julia R. Kuipers
✚
|
0.0 | |
|
BTR 2012 GST Trust for Matthew M. Rankin
✚
|
0.0 | |
|
Brown Advisory Investors 2023 - Axiom Series C, LLC
✚
|
0.0 |